NeuroMetrix, Inc. Warrants
NUROW
NUROW was delisted on the 26th of May, 2020.
2 hedge funds and large institutions have $0 invested in NeuroMetrix, Inc. Warrants in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$545 |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$453 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | +$453 | +1,372 | +67% |
|
|
2
UBS Group
Zurich,
Switzerland
| – | +$545 | +1,650 | +391% |
|
NUROW Hedge Fund Activity: Q4 2018 in Review
2 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Warrants (NUROW) for Q4 2018, worth a combined $0 — down 100% from $1K a quarter earlier.
Fund positioning in NUROW was balanced in Q4 2018: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $545.
- 2 institutional investors held NeuroMetrix, Inc. Warrants (NUROW) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $0 of NeuroMetrix, Inc. Warrants stock for Q4 2018, down 100% quarter-over-quarter.
- 0 funds opened new NeuroMetrix, Inc. Warrants positions in Q4 2018 and 0 closed out.
- The largest NeuroMetrix, Inc. Warrants buyer in Q4 2018 was UBS Group, an estimated $545 added.
Based on aggregated 13F filings for Q4 2018.